Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease
BACKGROUND: International guidelines advocate a 10 to 14-day course of systemic glucocorticoid therapy in the management of COPD exacerbations. The optimal duration of therapy is unknown and glucocorticoids have serious adverse effects. The aim of this trial is to demonstrate non-inferiority o...
Main Authors: | P Schuetz, M Briel, U Dürring, B Müller, C Schindler, S Viatte |
---|---|
Format: | Article |
Language: | English |
Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2010-10-01
|
Series: | Swiss Medical Weekly |
Subjects: | |
Online Access: | https://www.smw.ch/index.php/smw/article/view/1202 |
Similar Items
-
Glucocorticoid Use in Patients Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations
by: Yu S, et al.
Published: (2024-02-01) -
Predictors of re-exacerbation after an index exacerbation of chronic obstructive pulmonary disease in the REDUCE randomised clinical trial
by: Brigitte Engel, et al.
Published: (2017-05-01) -
THERAPY FOR EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: A. A. Zaitsev
Published: (2017-12-01) -
Exacerbations of chronic obstructive pulmonary disease: Time to rename
by: Bafadhel, M, et al.
Published: (2019) -
PATHOLOGIC PHYSIOLOGY OF EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: S. N. Avdeev
Published: (2019-05-01)